SOD1 and amyotrophic lateral sclerosis: Though a former study of patients with sALS found no association between CSF SOD1 and disease characteristics [90], it will be of great interest to examine, once the tofersen extension phase is complete, whether larger decreases in CSF SOD1 associate with greater improvements in clinical end-points in patients with SOD1 ALS.